Correlation Between Nuvalent and Icosavax
Can any of the company-specific risk be diversified away by investing in both Nuvalent and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvalent and Icosavax, you can compare the effects of market volatilities on Nuvalent and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Icosavax.
Diversification Opportunities for Nuvalent and Icosavax
Weak diversification
The 3 months correlation between Nuvalent and Icosavax is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of Nuvalent i.e., Nuvalent and Icosavax go up and down completely randomly.
Pair Corralation between Nuvalent and Icosavax
If you would invest 8,364 in Nuvalent on September 2, 2024 and sell it today you would earn a total of 1,304 from holding Nuvalent or generate 15.59% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 1.56% |
Values | Daily Returns |
Nuvalent vs. Icosavax
Performance |
Timeline |
Nuvalent |
Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Nuvalent and Icosavax Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nuvalent and Icosavax
The main advantage of trading using opposite Nuvalent and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |